Targeting NOS as a therapeutic approach for heart failure

Pharmacology and Therapeutics

Volumn 142, Issue 3, 2014, Pages 306-315

  Tang, Lifei ^a   Wang, Honglan ^a   Ziolo, Mark T ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Arrhythmia; cGMP; Contraction; Hypertrophy; Nitroso redox balance; S nitrosylation

Indexed keywords

CALCINEURIN; CAVEOLIN 3; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRANSCRIPTION FACTOR NFAT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ACTION POTENTIAL; ARRHYTHMOGENESIS; BINDING SITE; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; DIMERIZATION; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE DELETION; GENETIC TRANSCRIPTION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; IMMUNOPRECIPITATION; MUSCLE CELL; NITRATION; NITROSYLATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN TARGETING; PULMONARY ARTERY OCCLUSION PRESSURE; REVIEW; SARCOLEMMA; SARCOPLASMIC RETICULUM; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SUDDEN CARDIAC DEATH; ANIMAL; ANTAGONISTS AND INHIBITORS; ENZYMOLOGY; PHYSIOLOGY;

ANIMALS; HEART FAILURE; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; SIGNAL TRANSDUCTION;

EID: 84898851241     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2013.12.013     Document Type: Review

References (183)

1. X. Ai, J.W. Curran, T.R. Shannon, D.M. Bers, and S.M. Pogwizd Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure Circ Res 97 2005 1314 1322
2. P.J. Andrew, and B. Mayer Enzymatic function of nitric oxide synthases Cardiovasc Res 43 1999 521 531 (Pubitemid 29369251)
3. D.E. Arking, A. Pfeufer, W. Post, W.H. Kao, C. Newton-Cheh, and M. Ikeda et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization Nat Genet 38 2006 644 651 (Pubitemid 43927305)
4. A. Bailey, T.W. Pope, S.A. Moore, and C.L. Campbell The tragedy of TRIUMPH for nitric oxide synthesis inhibition in cardiogenic shock: Where do we go from here? Am J Cardiovasc Drugs 7 2007 337 345 (Pubitemid 47624537)
5. R.C. Balijepalli, J.D. Foell, D.D. Hall, J.W. Hell, and T.J. Kamp Localization of cardiac l-type Ca(2+) channels to a caveolar macromolecular signaling complex is required for beta(2)-adrenergic regulation Proc Natl Acad Sci U S A 103 2006 7500 7505 (Pubitemid 43727862)
6. J.L. Balligand, L. Kobzik, X. Han, D.M. Kaye, L. Belhassen, and D.S. O'Hara et al. Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes J Biol Chem 270 1995 14582 14586
7. J.L. Balligand, D. Ungureanu-Longrois, W.W. Simmons, D. Pimental, T.A. Malinski, and M. Kapturczak et al. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro J Biol Chem 269 1994 27580 27588
8. L.A. Barouch, R.W. Harrison, M.W. Skaf, G.O. Rosas, T.P. Cappola, and Z.A. Kobeissi et al. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms Nature 416 2002 337 339
9. A. Behling, L.E. Rohde, F.C. Colombo, L.A. Goldraich, R. Stein, and N. Clausell Effects of 5′-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: A double-blind, placebo-controlled clinical trial J Card Fail 14 2008 189 197 (Pubitemid 351444866)
10. J.K. Bendall, T. Damy, P. Ratajczak, X. Loyer, V. Monceau, and I. Marty et al. Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat Circulation 110 2004 2368 2375 (Pubitemid 39407341)
11. C.E. Berry, and J.M. Hare Xanthine oxidoreductase and cardiovascular disease: Molecular mechanisms and pathophysiological implications J Physiol 555 2004 589 606 (Pubitemid 38404582)
12. D.M. Bers Cardiac excitation-contraction coupling Nature 415 2002 198 205 (Pubitemid 34059525)
13. K.O. Bonsu, A. Kadirvelu, and D.D. Reidpath Statins in heart failure: Do we need another trial? Vasc Health Risk Manag 9 2013 303 319
14. G.W. Booz Putting the brakes on cardiac hypertrophy: Exploiting the NO-cGMP counter-regulatory system Hypertension 45 2005 341 346 (Pubitemid 40315798)
15. M.V. Brahmajothi, and D.L. Campbell Heterogeneous basal expression of nitric oxide synthase and superoxide dismutase isoforms in mammalian heart: Implications for mechanisms governing indirect and direct nitric oxide-related effects Circ Res 85 1999 575 587 (Pubitemid 29467846)
16. K. Brixius, Q. Song, A. Malick, B. Boelck, K. Addicks, and W. Bloch et al. ENOS is not activated by nebivolol in human failing myocardium Life Sci 79 2006 1234 1241 (Pubitemid 44209171)
17. F. Brunner, P. Andrew, G. Wolkart, R. Zechner, and B. Mayer Myocardial contractile function and heart rate in mice with myocyte-specific overexpression of endothelial nitric oxide synthase Circulation 104 2001 3097 3102 (Pubitemid 34014064)
18. D.E. Burger, X. Lu, M. Lei, F.L. Xiang, L. Hammoud, and M. Jiang et al. Neuronal nitric oxide synthase protects against myocardial infarction-induced ventricular arrhythmia and mortality in mice Circulation 120 2009 1345 1354
19. J.R. Burgoyne, and P. Eaton Transnitrosylating nitric oxide species directly activate type I protein kinase A, providing a novel adenylate cyclase-independent cross-talk to beta-adrenergic-like signaling J Biol Chem 284 2009 29260 29268
20. N. Burkard, T. Williams, M. Czolbe, N. Blomer, F. Panther, and M. Link et al. Conditional overexpression of neuronal nitric oxide synthase is cardioprotective in ischemia/reperfusion Circulation 122 2010 1588 1603
21. R. Busse, and A. Mulsch Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin FEBS Lett 265 1990 133 136 (Pubitemid 20189413)
22. E.S. Buys, M.J. Raher, S.L. Blake, T.G. Neilan, A.R. Graveline, and J.J. Passeri et al. Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload Am J Physiol Heart Circ Physiol 293 2007 H620 H627
23. H.C. Champion, D. Georgakopoulos, E. Takimoto, T. Isoda, Y. Wang, and D.A. Kass Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3 Circ Res 94 2004 657 663 (Pubitemid 38387749)
24. C.A. Chen, T.Y. Wang, S. Varadharaj, L.A. Reyes, C. Hemann, and M.A. Talukder et al. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function Nature 468 2010 1115 1118
25. H.J. Cho, Q.W. Xie, J. Calaycay, R.A. Mumford, K.M. Swiderek, and T.D. Lee et al. Calmodulin is a subunit of nitric oxide synthase from macrophages J Exp Med 176 1992 599 604
26. L. Cominacini, A. Fratta Pasini, U. Garbin, C. Nava, A. Davoli, and M. Criscuoli et al. Nebivolol and its 4-keto derivative increase nitric oxide in endothelial cells by reducing its oxidative inactivation J Am Coll Cardiol 42 2003 1838 1844 (Pubitemid 37433667)
27. M.J. Crabtree, A.L. Tatham, Y. Al-Wakeel, N. Warrick, A.B. Hale, and S. Cai et al. Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: Insights from cells with tet-regulated GTP cyclohydrolase I expression J Biol Chem 284 2009 1136 1144
28. J. Curran, K.H. Brown, D.J. Santiago, S. Pogwizd, D.M. Bers, and T.R. Shannon Spontaneous Ca waves in ventricular myocytes from failing hearts depend on Ca(2+)-calmodulin-dependent protein kinase II J Mol Cell Cardiol 49 2010 25 32
29. T. Damy, P. Ratajczak, E. Robidel, J.K. Bendall, P. Oliviero, and J. Boczkowski et al. Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats FASEB J 17 2003 1934 1936
30. T. Damy, P. Ratajczak, A.M. Shah, E. Camors, I. Marty, and G. Hasenfuss et al. Increased neuronal nitric oxide synthase-derived NO production in the failing human heart Lancet 363 2004 1365 1367 (Pubitemid 38529877)
31. D. Dawson, C.A. Lygate, M.H. Zhang, K. Hulbert, S. Neubauer, and B. Casadei nNOS gene deletion exacerbates pathological left ventricular remodeling and functional deterioration after myocardial infarction Circulation 112 2005 3729 3737 (Pubitemid 43739513)
32. F.A. Dias, D. Urboniene, M.A. Yuzhakova, B.J. Biesiadecki, J.R. Pena, and P.H. Goldspink et al. Ablation of iNOS delays cardiac contractile dysfunction in chronic hypertension Front Biosci (Elite Ed) 2 2010 312 324
33. S. Dikalov, B. Fink, M. Skatchkov, and E. Bassenge Comparison of glyceryl trinitrate-induced with pentaerythrityl tetranitrate-induced in vivo formation of superoxide radicals: Effect of vitamin C Free Radic Biol Med 27 1999 170 176 (Pubitemid 29353097)
34. R.A. Dulce, O. Yiginer, D.R. Gonzalez, G. Goss, N. Feng, and M. Zheng et al. Hydralazine and organic nitrates restore impaired excitation-contraction coupling by reducing calcium leak associated with nitroso-redox imbalance J Biol Chem 288 2013 6522 6533
35. U.E. Ekelund, R.W. Harrison, O. Shokek, R.N. Thakkar, R.S. Tunin, and H. Senzaki et al. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure Circ Res 85 1999 437 445 (Pubitemid 29409620)
36. J.R. Erickson, M.L. Joiner, X. Guan, W. Kutschke, J. Yang, and C.V. Oddis et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation Cell 133 2008 462 474 (Pubitemid 351608692)
37. E.C. Feiner, P. Chung, J.F. Jasmin, J. Zhang, D. Whitaker-Menezes, and V. Myers et al. Left ventricular dysfunction in murine models of heart failure and in failing human heart is associated with a selective decrease in the expression of caveolin-3 J Card Fail 17 2011 253 263
38. D.S. Feldman, T.S. Elton, B. Sun, M.M. Martin, and M.T. Ziolo Mechanisms of disease: Detrimental adrenergic signaling in acute decompensated heart failure Nat Clin Pract Cardiovasc Med 5 2008 208 218 (Pubitemid 351472165)
39. P. Ferdinandy, H. Danial, I. Ambrus, R.A. Rothery, and R. Schulz Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure Circ Res 87 2000 241 247 (Pubitemid 30626433)
40. O. Feron, C. Dessy, D.J. Opel, M.A. Arstall, R.A. Kelly, and T. Michel Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate J Biol Chem 273 1998 30249 30254 (Pubitemid 28545491)
41. M. Ferreiro, A.D. Petrosky, and A.L. Escobar Intracellular Ca2+ release underlies the development of phase 2 in mouse ventricular action potentials Am J Physiol Heart Circ Physiol 302 2012 H1160 H1172
42. B. Fiedler, S.M. Lohmann, A. Smolenski, S. Linnemuller, B. Pieske, and F. Schroder et al. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes Proc Natl Acad Sci U S A 99 2002 11363 11368 (Pubitemid 34920931)
43. I. Fleming, and R. Busse Signal transduction of eNOS activation Cardiovasc Res 43 1999 532 541 (Pubitemid 29369252)
44. U. Forstermann, and T. Munzel Endothelial nitric oxide synthase in vascular disease: From marvel to menace Circulation 113 2006 1708 1714
45. H. Fukushima, N. Kobayashi, H. Takeshima, W. Koguchi, and T. Ishimitsu Effects of olmesartan on Apelin/APJ and Akt/endothelial nitric oxide synthase pathway in Dahl rats with end-stage heart failure J Cardiovasc Pharmacol 55 2010 83 88
46. D. Fulton, J.P. Gratton, T.J. McCabe, J. Fontana, Y. Fujio, and K. Walsh et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt Nature 399 1999 597 601
47. M. Gheorghiade, S.J. Greene, G. Filippatos, E. Erdmann, R. Ferrari, and P.D. Levy et al. Cinaciguat, a soluble guanylate cyclase activator: Results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes Eur J Heart Fail 14 2012 1056 1066
48. A.S. Go, D. Mozaffarian, V.L. Roger, E.J. Benjamin, J.D. Berry, and W.B. Borden et al. Executive summary: Heart disease and stroke statistics - 2013 update: A report from the American Heart Association Circulation 127 2013 143 152
49. D.R. Gonzalez, F. Beigi, A.V. Treuer, and J.M. Hare Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes Proc Natl Acad Sci U S A 104 2007 20612 20617
50. D.R. Gonzalez, A.V. Treuer, J. Castellanos, R.A. Dulce, and J.M. Hare Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure J Biol Chem 285 2010 28938 28945
51. M. Guazzi, M. Vicenzi, R. Arena, and M.D. Guazzi PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: Results of a 1-year, prospective, randomized, placebo-controlled study Circ Heart Fail 4 2011 8 17
52. R. Gyurko, P. Kuhlencordt, M.C. Fishman, and P.L. Huang Modulation of mouse cardiac function in vivo by eNOS and ANP Am J Physiol Heart Circ Physiol 278 2000 H971 H981
53. A.D. Hafstad, A.A. Nabeebaccus, and A.M. Shah Novel aspects of ROS signalling in heart failure Basic Res Cardiol 108 2013 359
54. J.M. Hare, B. Mangal, J. Brown, C. Fisher Jr., R. Freudenberger, and W.S. Colucci et al. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study J Am Coll Cardiol 51 2008 2301 2309 (Pubitemid 351783365)
55. C. Heymes, M. Vanderheyden, J.G. Bronzwaer, A.M. Shah, and W.J. Paulus Endomyocardial nitric oxide synthase and left ventricular preload reserve in dilated cardiomyopathy Circulation 99 1999 3009 3016 (Pubitemid 29270430)
56. S.R. Houser, K.B. Margulies, A.M. Murphy, F.G. Spinale, G.S. Francis, and S.D. Prabhu et al. Animal models of heart failure: A scientific statement from the American Heart Association Circ Res 111 2012 131 150
57. S.R. Houser, and J.D. Molkentin Does contractile Ca2+ control calcineurin-NFAT signaling and pathological hypertrophy in cardiac myocytes? Sci Signal 1 2008 pe31
58. S.R. Houser, V. Piacentino III, and J. Weisser Abnormalities of calcium cycling in the hypertrophied and failing heart J Mol Cell Cardiol 32 2000 1595 1607
59. A. Hu, X. Jiao, E. Gao, W.J. Koch, S. Sharifi-Azad, and Z. Grunwald et al. Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress J Pharmacol Exp Ther 318 2006 469 475 (Pubitemid 44061219)
60. B. Huang, S. Wang, D. Qin, M. Boutjdir, and N. El-Sherif Diminished basal phosphorylation level of phospholamban in the postinfarction remodeled rat ventricle: Role of beta-adrenergic pathway, G(i) protein, phosphodiesterase, and phosphatases Circ Res 85 1999 848 855 (Pubitemid 29504160)
61. R.E. Huie, and S. Padmaja The reaction of no with superoxide Free Radic Res Commun 18 1993 195 199
62. K. Ichimori, M. Fukahori, H. Nakazawa, K. Okamoto, and T. Nishino Inhibition of xanthine oxidase and xanthine dehydrogenase by nitric oxide. Nitric oxide converts reduced xanthine-oxidizing enzymes into the desulfo-type inactive form J Biol Chem 274 1999 7763 7768
63. F. Ichinose, R. Hataishi, J.C. Wu, N. Kawai, A.C. Rodrigues, and C. Mallari et al. A selective inducible NOS dimerization inhibitor prevents systemic, cardiac, and pulmonary hemodynamic dysfunction in endotoxemic mice Am J Physiol Heart Circ Physiol 285 2003 H2524 H2530
64. L.J. Ignarro Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol Cardiovasc Ther 26 2008 115 134 (Pubitemid 351952828)
65. Y. Ishimura, Y.T. Gao, S.P. Panda, L.J. Roman, B.S. Masters, and S.T. Weintraub Detection of nitrous oxide in the neuronal nitric oxide synthase reaction by gas chromatography-mass spectrometry Biochem Biophys Res Commun 338 2005 543 549 (Pubitemid 41540601)
66. C.T. January, and J.M. Riddle Early afterdepolarizations: Mechanism of induction and block. A role for l-type Ca2+ current Circ Res 64 1989 977 990 (Pubitemid 19117651)
67. N. Kaludercic, E. Takimoto, T. Nagayama, N. Feng, E.W. Lai, and D. Bedja et al. Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload Circ Res 106 2010 193 202
68. W.H. Kao, D.E. Arking, W. Post, T.D. Rea, N. Sotoodehnia, and R.J. Prineas et al. Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populations Circulation 119 2009 940 951
69. S. Kawano, T. Kubota, Y. Monden, T. Tsutsumi, T. Inoue, and N. Kawamura et al. Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction Am J Physiol Heart Circ Physiol 291 2006 H1337 H1344
70. S.A. Khan, K. Lee, K.M. Minhas, D.R. Gonzalez, S.V. Raju, and A.D. Tejani et al. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling Proc Natl Acad Sci U S A 101 2004 15944 15948 (Pubitemid 39507906)
71. S.A. Khan, M.W. Skaf, R.W. Harrison, K. Lee, K.M. Minhas, and A. Kumar et al. Nitric oxide regulation of myocardial contractility and calcium cycling: Independent impact of neuronal and endothelial nitric oxide synthases Circ Res 92 2003 1322 1329 (Pubitemid 36773474)
72. K.H. Kim, H.K. Kim, I.C. Hwang, S.P. Lee, H.J. Cho, and H.J. Kang et al. ULTIMATE-SHF trial (UdenafiL Therapy to Improve symptoMAtology, exercise Tolerance and hEmodynamics in patients with chronic systolic heart failure): Study protocol for a randomized, placebo-controlled, double-blind trial Trials 14 2013 188
73. S. Kinugawa, H. Huang, Z. Wang, P.M. Kaminski, M.S. Wolin, and T.H. Hintze A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase Circ Res 96 2005 355 362 (Pubitemid 40279910)
74. R.G. Knowles, and S. Moncada Nitric oxide synthases in mammals Biochem J 298 Pt 2 1994 249 258 (Pubitemid 24072462)
75. R.G. Knowles, M. Palacios, R.M. Palmer, and S. Moncada Formation of nitric oxide from l-arginine in the central nervous system: A transduction mechanism for stimulation of the soluble guanylate cyclase Proc Natl Acad Sci U S A 86 1989 5159 5162 (Pubitemid 19182253)
76. M.J. Kohr, J.P. Davis, and M.T. Ziolo Peroxynitrite increases protein phosphatase activity and promotes the interaction of phospholamban with protein phosphatase 2a in the myocardium Nitric Oxide 20 2009 217 221
77. M.J. Kohr, N. Kaludercic, C.G. Tocchetti, W. Dong Gao, D.A. Kass, and P.M. Janssen et al. Nitroxyl enhances myocyte Ca2+ transients by exclusively targeting SR Ca2+-cycling Front Biosci 2 2010 614 626
78. M.J. Kohr, S.R. Roof, J.L. Zweier, and M.T. Ziolo Modulation of myocardial contraction by peroxynitrite Front Physiol 3 2012 468
79. M.J. Kohr, C.J. Traynham, S.R. Roof, J.P. Davis, and M.T. Ziolo cAMP-independent activation of protein kinase A by the peroxynitrite generator SIN-1 elicits positive inotropic effects in cardiomyocytes J Mol Cell Cardiol 48 2010 645 648
80. M.J. Kohr, H. Wang, D.G. Wheeler, M. Velayutham, J.L. Zweier, and M.T. Ziolo Biphasic effect of SIN-1 is reliant upon cardiomyocyte contractile state Free Radic Biol Med 45 2008 73 80
81. M.J. Kohr, H. Wang, D.G. Wheeler, M. Velayutham, J.L. Zweier, and M.T. Ziolo Targeting of phospholamban by peroxynitrite decreases {beta}-adrenergic stimulation in cardiomyocytes Cardiovasc Res 77 2008 353 361 (Pubitemid 351197637)
82. G. Kojda, K. Kottenberg, P. Nix, K.D. Schluter, H.M. Piper, and E. Noack Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes Circ Res 78 1996 91 101 (Pubitemid 26004125)
83. K. Kondo, S. Bhushan, A.L. King, S.D. Prabhu, T. Hamid, and S. Koenig et al. H(2)S protects against pressure overload-induced heart failure via upregulation of endothelial nitric oxide synthase Circulation 127 2013 1116 1127
84. J. Layland, J.M. Li, and A.M. Shah Role of cyclic GMP-dependent protein kinase in the contractile response to exogenous nitric oxide in rat cardiac myocytes J Physiol 540 2002 457 467 (Pubitemid 35190124)
85. J.M. Li, N.P. Gall, D.J. Grieve, M. Chen, and A.M. Shah Activation of NADPH oxidase during progression of cardiac hypertrophy to failure Hypertension 40 2002 477 484
86. Q. Liu, and P.A. Hofmann Protein phosphatase 2A-mediated cross-talk between p38 MAPK and ERK in apoptosis of cardiac myocytes Am J Physiol Heart Circ Physiol 286 2004 H2204 H2212
87. E. Lonn, J. Bosch, S. Yusuf, P. Sheridan, J. Pogue, and J.M. Arnold et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: A randomized controlled trial JAMA 293 2005 1338 1347 (Pubitemid 40381486)
88. N. Loukili, N. Rosenblatt-Velin, J. Rolli, S. Levrand, F. Feihl, and B. Waeber et al. Oxidants positively or negatively regulate nuclear factor kappaB in a context-dependent manner J Biol Chem 285 2010 15746 15752
89. C.J. Lowenstein, C.S. Glatt, D.S. Bredt, and S.H. Snyder Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme Proc Natl Acad Sci U S A 89 1992 6711 6715
90. X. Loyer, A.M. Gomez, P. Milliez, M. Fernandez-Velasco, P. Vangheluwe, and L. Vinet et al. Cardiomyocyte overexpression of neuronal nitric oxide synthase delays transition toward heart failure in response to pressure overload by preserving calcium cycling Circulation 117 2008 3187 3198
91. L.S. Maier CaMKIIdelta overexpression in hypertrophy and heart failure: Cellular consequences for excitation-contraction coupling Braz J Med Biol Res 38 2005 1293 1302 (Pubitemid 41288413)
92. S.R. Martin, K. Emanuel, C.E. Sears, Y.H. Zhang, and B. Casadei Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation Cardiovasc Res 70 2006 97 106
93. P.B. Massion, C. Dessy, F. Desjardins, M. Pelat, X. Havaux, and C. Belge et al. Cardiomyocyte-restricted overexpression of endothelial nitric oxide synthase (NOS3) attenuates beta-adrenergic stimulation and reinforces vagal inhibition of cardiac contraction Circulation 110 2004 2666 2672 (Pubitemid 39453017)
94. B. Mayer, and B. Hemmens Biosynthesis and action of nitric oxide in mammalian cells Trends Biochem Sci 22 1997 477 481 (Pubitemid 27515914)
95. K.M. Minhas, R.M. Saraiva, K.H. Schuleri, S. Lehrke, M. Zheng, and A.P. Saliaris et al. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy Circ Res 98 2006 271 279
96. M. Mochizuki, M. Yano, T. Oda, H. Tateishi, S. Kobayashi, and T. Yamamoto et al. Scavenging free radicals by low-dose carvedilol prevents redox-dependent Ca2+ leak via stabilization of ryanodine receptor in heart failure J Am Coll Cardiol 49 2007 1722 1732 (Pubitemid 46589924)
97. A.L. Moens, E.A. Ketner, E. Takimoto, T.S. Schmidt, C.A. O'Neill, and M.S. Wolin et al. Bi-modal dose-dependent cardiac response to tetrahydrobiopterin in pressure-overload induced hypertrophy and heart failure J Mol Cell Cardiol 51 2011 564 569
98. A.L. Moens, R. Kietadisorn, J.Y. Lin, and D. Kass Targeting endothelial and myocardial dysfunction with tetrahydrobiopterin J Mol Cell Cardiol 51 2011 559 563
99. A.L. Moens, E. Takimoto, C.G. Tocchetti, K. Chakir, D. Bedja, and G. Cormaci et al. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: Efficacy of recoupling nitric oxide synthase as a therapeutic strategy Circulation 117 2008 2626 2636
100. G. Nasr, and C. Maurice Allopurinol and global left myocardial function in heart failure patients J Cardiovasc Dis Res 1 2010 191 195
101. S. Neef, C.M. Sag, M. Daut, H. Baumer, C. Grefe, and A. El-Armouche et al. While systolic cardiomyocyte function is preserved, diastolic myocyte function and recovery from acidosis are impaired in CaMKIIdelta-KO mice J Mol Cell Cardiol 59 2013 107 116
102. J.M. Nerbonne, and R.S. Kass Molecular physiology of cardiac repolarization Physiol Rev 85 2005 1205 1253 (Pubitemid 41362269)
103. D. Oceandy, E.J. Cartwright, M. Emerson, S. Prehar, F.M. Baudoin, and M. Zi et al. Neuronal nitric oxide synthase signaling in the heart is regulated by the sarcolemmal calcium pump 4b Circulation 115 2007 483 492 (Pubitemid 46184200)
104. C.V. Oddis, and M.S. Finkel NF-kappa B and GTP cyclohydrolase regulate cytokine-induced nitric oxide production by cardiac myocytes Am J Physiol 270 1996 H1864 H1868
105. R.M. Palmer, D.S. Ashton, and S. Moncada Vascular endothelial cells synthesize nitric oxide from l-arginine Nature 333 1988 664 666
106. R.M. Palmer, A.G. Ferrige, and S. Moncada Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327 1987 524 526 (Pubitemid 17085822)
107. N. Paolocci, R. Biondi, M. Bettini, C.I. Lee, C.O. Berlowitz, and R. Rossi et al. Oxygen radical-mediated reduction in basal and agonist-evoked NO release in isolated rat heart J Mol Cell Cardiol 33 2001 671 679 (Pubitemid 32538980)
108. W.J. Paulus Beneficial effects of nitric oxide on cardiac diastolic function: 'The flip side of the coin' Heart Fail Rev 5 2000 337 344 (Pubitemid 32000431)
109. A. Piech, P.E. Massart, C. Dessy, O. Feron, X. Havaux, and N. Morel et al. Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy Am J Physiol Heart Circ Physiol 282 2002 H219 H231
110. S.M. Pogwizd, and D.M. Bers Cellular basis of triggered arrhythmias in heart failure Trends Cardiovasc Med 14 2004 61 66 (Pubitemid 38340848)
111. B.L. Predmore, D. Julian, and A.J. Cardounel Hydrogen sulfide increases nitric oxide production from endothelial cells by an akt-dependent mechanism Front Physiol 2 2011 104
112. F. Qin, M. Simeone, and R. Patel Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction Free Radic Biol Med 43 2007 271 281 (Pubitemid 46977168)
113. A. Rakhit, C.T. Maguire, H. Wakimoto, J. Gehrmann, G.K. Li, and R.A. Kelly et al. In vivo electrophysiologic studies in endothelial nitric oxide synthase (eNOS)-deficient mice J Cardiovasc Electrophysiol 12 2001 1295 1301 (Pubitemid 33111900)
114. M.M. Redfield, H.H. Chen, B.A. Borlaug, M.J. Semigran, K.L. Lee, and G. Lewis et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: A randomized clinical trial JAMA 309 2013 1268 1277
115. S.R. Roof, B.J. Biesiadecki, J.P. Davis, P.M. Janssen, and M.T. Ziolo Effects of increased systolic Ca(2+) and beta-adrenergic stimulation on Ca(2+) transient decline in NOS1 knockout cardiac myocytes Nitric Oxide 27 2012 242 247
116. 2+ transient kinetics in cardiac myocytes Am J Physiol Heart Circ Physiol 301 2011 H1570 H1578
117. S.R. Roof, L. Tang, J.E. Ostler, M. Periasamy, S. Gyorke, and G.E. Billman et al. Neuronal nitric oxide synthase is indispensable for the cardiac adaptive effects of exercise Basic Res Cardiol 108 2013 332
118. W.F. Saavedra, N. Paolocci, M.E. St John, M.W. Skaf, G.C. Stewart, and J.S. Xie et al. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart Circ Res 90 2002 297 304 (Pubitemid 34633931)
119. H.N. Sabbah, C.G. Tocchetti, M. Wang, S. Daya, R.C. Gupta, and R.S. Tunin et al. Nitroxyl (HNO) a novel approach for the acute treatment of heart failure Circ Heart Fail 6 2013 1250 1258
120. C.M. Sag, S. Wagner, and L.S. Maier Role of oxidants on calcium and sodium movement in healthy and diseased cardiac myocytes Free Radic Biol Med 63 2013 338 349
121. F. Sam, D.L. Kerstetter, D.R. Pimental, S. Mulukutla, A. Tabaee, and M.R. Bristow et al. Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium J Card Fail 11 2005 473 480
122. F. Sam, D.B. Sawyer, Z. Xie, D.L. Chang, S. Ngoy, and D.A. Brenner et al. Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction Circ Res 89 2001 351 356 (Pubitemid 34132674)
123. R.M. Saraiva, K.M. Minhas, S.V. Raju, L.A. Barouch, E. Pitz, and K.H. Schuleri et al. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: Role of nitroso-redox equilibrium Circulation 112 2005 3415 3422 (Pubitemid 43739556)
124. M. Scherrer-Crosbie, R. Ullrich, K.D. Bloch, H. Nakajima, B. Nasseri, and H.T. Aretz et al. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice Circulation 104 2001 1286 1291 (Pubitemid 32848119)
125. H.H. Schmidt, H. Hofmann, U. Schindler, Z.S. Shutenko, D.D. Cunningham, and M. Feelisch No.NO from NO synthase Proc Natl Acad Sci U S A 93 1996 14492 14497
126. R. Schulz, E. Nava, and S. Moncada Induction and potential biological relevance of a Ca(2+)-independent nitric oxide synthase in the myocardium Br J Pharmacol 105 1992 575 580
127. R.H. Schwinger, G. Munch, B. Bolck, P. Karczewski, E.G. Krause, and E. Erdmann Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation J Mol Cell Cardiol 31 1999 479 491 (Pubitemid 29121635)
128. C.E. Sears, S.M. Bryant, E.A. Ashley, C.A. Lygate, S. Rakovic, and H.L. Wallis et al. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling Circ Res 92 2003 e52 e59
129. T.R. Shannon, K.S. Ginsburg, and D.M. Bers Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration Biophys J 78 2000 334 343 (Pubitemid 30207142)
130. V. Sivakumaran, B.A. Stanley, C.G. Tocchetti, J.D. Ballin, V. Caceres, and L. Zhou et al. HNO Enhances SERCA2a activity and cardiomyocyte function by promoting redox-dependent phospholamban oligomerization Antioxid Redox Signal 19 2013 1185 1197
131. D. Sommer, S. Coleman, S.A. Swanson, and P.M. Stemmer Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress Arch Biochem Biophys 404 2002 271 278 (Pubitemid 34913558)
132. J.S. Stamler, S. Lamas, and F.C. Fang Nitrosylation. The prototypic redox-based signaling mechanism Cell 106 2001 675 683 (Pubitemid 32900659)
133. A. Stangherlin, F. Gesellchen, A. Zoccarato, A. Terrin, L.A. Fields, and M. Berrera et al. cGMP signals modulate cAMP levels in a compartment-specific manner to regulate catecholamine-dependent signaling in cardiac myocytes Circ Res 108 2011 929 939
134. D.J. Stuehr, N.S. Kwon, C.F. Nathan, O.W. Griffith, P.L. Feldman, and J. Wiseman N omega-hydroxy-l-arginine is an intermediate in the biosynthesis of nitric oxide from l-arginine J Biol Chem 266 1991 6259 6263 (Pubitemid 21906212)
135. D. Stuehr, S. Pou, and G.M. Rosen Oxygen reduction by nitric-oxide synthases J Biol Chem 276 2001 14533 14536 (Pubitemid 37373319)
136. J. Sun, L.J. Druhan, and J.L. Zweier Dose dependent effects of reactive oxygen and nitrogen species on the function of neuronal nitric oxide synthase Arch Biochem Biophys 471 2008 126 133 (Pubitemid 351308077)
137. J. Sun, E. Picht, K.S. Ginsburg, D.M. Bers, C. Steenbergen, and E. Murphy Hypercontractile female hearts exhibit increased S-nitrosylation of the l-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury Circ Res 98 2006 403 411
138. K. Szocs, B. Lassegue, P. Wenzel, M. Wendt, A. Daiber, and M. Oelze et al. Increased superoxide production in nitrate tolerance is associated with NAD(P)H oxidase and aldehyde dehydrogenase 2 downregulation J Mol Cell Cardiol 42 2007 1111 1118 (Pubitemid 46829198)
139. E. Takimoto, H.C. Champion, M. Li, D. Belardi, S. Ren, and E.R. Rodriguez et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy Nat Med 11 2005 214 222 (Pubitemid 40321358)
140. E. Takimoto, H.C. Champion, M. Li, S. Ren, E.R. Rodriguez, and B. Tavazzi et al. Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load J Clin Invest 115 2005 1221 1231 (Pubitemid 40629040)
141. A.L. Taylor, S. Ziesche, C. Yancy, P. Carson, R. D'Agostino Jr., and K. Ferdinand et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
142. D. Terentyev, I. Gyorke, A.E. Belevych, R. Terentyeva, A. Sridhar, and Y. Nishijima et al. Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure Circ Res 103 2008 1466 1472
143. L. Timmers, J.K. van Keulen, I.E. Hoefer, M.F. Meijs, B. van Middelaar, and K. den Ouden et al. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction Circ Res 104 2009 699 706
144. C.G. Tocchetti, W. Wang, J.P. Froehlich, S. Huke, M.A. Aon, and G.M. Wilson et al. Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling Circ Res 100 2007 96 104 (Pubitemid 46066777)
145. C.J. Traynham, S.R. Roof, H. Wang, R.A. Prosak, L. Tang, and S. Viatchenko-Karpinski et al. Diesterified nitrone rescues nitroso-redox levels and increases myocyte contraction via increased SR Ca(2+) handling PLoS One 7 2012 e52005
146. D. Tweedie, S.E. Harding, and K.T. MacLeod Sarcoplasmic reticulum Ca content, sarcolemmal Ca influx and the genesis of arrhythmias in isolated guinea-pig cardiomyocytes J Mol Cell Cardiol 32 2000 261 272 (Pubitemid 30670348)
147. K. Ueda, C. Valdivia, A. Medeiros-Domingo, D.J. Tester, M. Vatta, and G. Farrugia et al. Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex Proc Natl Acad Sci U S A 105 2008 9355 9360
148. R. Ullrich, M. Scherrer-Crosbie, K.D. Bloch, F. Ichinose, H. Nakajima, and M.H. Picard et al. Congenital deficiency of nitric oxide synthase 2 protects against endotoxin-induced myocardial dysfunction in mice Circulation 102 2000 1440 1446
149. K. Van der Heiden, S. Cuhlmann, A. Luong le, M. Zakkar, and P.C. Evans Role of nuclear factor kappaB in cardiovascular health and disease Clin Sci (Lond) 118 2010 593 605
150. S. Vandenwijngaert, P. Pokreisz, H. Hermans, H. Gillijns, M. Pellens, and N.A. Bax et al. Increased cardiac myocyte PDE5 levels in human and murine pressure overload hypertrophy contribute to adverse LV remodeling PLoS One 8 2013 e58841
151. G. Vaniotis, I. Glazkova, C. Merlen, C. Smith, L.R. Villeneuve, and D. Chatenet et al. Regulation of cardiac nitric oxide signaling by nuclear beta-adrenergic and endothelin receptors J Mol Cell Cardiol 62 2013 58 68
152. J. Vasquez-Vivar, B. Kalyanaraman, P. Martasek, N. Hogg, B.S. Masters, and H. Karoui et al. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors Proc Natl Acad Sci U S A 95 1998 9220 9225 (Pubitemid 28506212)
153. H. Wang, I.M. Bonilla, X. Huang, Q. He, M.J. Kohr, and C.A. Carnes et al. Prolonged action potential and after depolarizations are not due to changes in potassium currents in NOS3 knockout ventricular myocytes J Signal Transduct 645721 2012
154. W. Wang, H. Fang, L. Groom, A. Cheng, W. Zhang, and J. Liu et al. Superoxide flashes in single mitochondria Cell 134 2008 279 290 (Pubitemid 352010332)
155. H. Wang, M.J. Kohr, C.J. Traynham, D.G. Wheeler, P.M. Janssen, and M.T. Ziolo Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban Am J Physiol Cell Physiol 294 2008 C1566 C1575
156. H. Wang, M.J. Kohr, C.J. Traynham, and M.T. Ziolo Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to l-type Ca2+ current in cardiac myocytes J Mol Cell Cardiol 47 2009 304 314
157. H. Wang, M.J. Kohr, D.G. Wheeler, and M.T. Ziolo Endothelial nitric oxide synthase decreases beta-adrenergic responsiveness via inhibition of the l-type Ca2+ current Am J Physiol Heart Circ Physiol 294 2008 H1473 H1480
158. H. Wang, S. Viatchenko-Karpinski, J. Sun, I. Gyorke, N.A. Benkusky, and M.J. Kohr et al. Regulation of myocyte contraction via neuronal nitric oxide synthase: Role of ryanodine receptor S-nitrosylation J Physiol 588 2010 2905 2917
159. S. Wassmann, U. Laufs, K. Muller, C. Konkol, K. Ahlbory, and A.T. Baumer et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo Arterioscler Thromb Vasc Biol 22 2002 300 305 (Pubitemid 34127043)
160. Y. Watanabe, K. Watanabe, T. Kobayashi, Y. Saito, D. Fujioka, and T. Nakamura et al. Chronic depletion of glutathione exacerbates ventricular remodelling and dysfunction in the pressure-overloaded heart Cardiovasc Res 97 2013 282 292
161. S. Wenzel, C. Rohde, S. Wingerning, J. Roth, G. Kojda, and K.D. Schluter Lack of endothelial nitric oxide synthase-derived nitric oxide formation favors hypertrophy in adult ventricular cardiomyocytes Hypertension 49 2007 193 200 (Pubitemid 46360360)
162. S.M. Wildhirt, S. Weismueller, C. Schulze, N. Conrad, A. Kornberg, and B. Reichart Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: Evidence for a late phase of nitric oxide-mediated reperfusion injury Cardiovasc Res 43 1999 698 711 (Pubitemid 29369268)
163. J.C. Williams, A.L. Armesilla, T.M. Mohamed, C.L. Hagarty, F.H. McIntyre, and S. Schomburg et al. The sarcolemmal calcium pump, alpha-1 syntrophin, and neuronal nitric-oxide synthase are parts of a macromolecular protein complex J Biol Chem 281 2006 23341 23348 (Pubitemid 44274108)
164. P. Wohlfart, H. Xu, A. Endlich, A. Habermeier, E.I. Closs, and T. Hubschle et al. Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling J Pharmacol Exp Ther 325 2008 370 379 (Pubitemid 351574784)
165. Y. Xia, V.L. Dawson, T.M. Dawson, S.H. Snyder, and J.L. Zweier Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury Proc Natl Acad Sci U S A 93 1996 6770 6774
166. Y. Xia, A.L. Tsai, V. Berka, and J.L. Zweier Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process J Biol Chem 273 1998 25804 25808
167. K.Y. Xu, D.L. Huso, T.M. Dawson, D.S. Bredt, and L.C. Becker Nitric oxide synthase in cardiac sarcoplasmic reticulum Proc Natl Acad Sci U S A 96 1999 657 662 (Pubitemid 29061264)
168. B. Yang, D.F. Larson, and R.R. Watson Modulation of iNOS activity in age-related cardiac dysfunction Life Sci 75 2004 655 667 (Pubitemid 38686697)
169. L. Yang, G. Liu, S.I. Zakharov, A.M. Bellinger, M. Mongillo, and S.O. Marx Protein kinase G phosphorylates Cav1.2 alpha1c and beta2 subunits Circ Res 101 2007 465 474 (Pubitemid 47347877)
170. X.W. Yu, Q. Chen, R.H. Kennedy, and S.J. Liu Inhibition of sarcoplasmic reticular function by chronic interleukin-6 exposure via iNOS in adult ventricular myocytes J Physiol 566 2005 327 340 (Pubitemid 41030543)
171. Y.H. Zhang, L. Dingle, R. Hall, and B. Casadei The role of nitric oxide and reactive oxygen species in the positive inotropic response to mechanical stretch in the mammalian myocardium Biochim Biophys Acta 1787 2009 811 817
172. P. Zhang, X. Xu, X. Hu, E.D. van Deel, G. Zhu, and Y. Chen Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure Circ Res 100 2007 1089 1098 (Pubitemid 46598934)
173. Y.H. Zhang, M.H. Zhang, C.E. Sears, K. Emanuel, C. Redwood, and A. El-Armouche et al. Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice Circ Res 102 2008 242 249 (Pubitemid 351651129)
174. M.T. Ziolo The fork in the nitric oxide road: Cyclic GMP or nitrosylation? Nitric Oxide 18 2008 153 156
175. M.T. Ziolo, and D.M. Bers The real estate of NOS signaling: Location, location, location Circ Res 92 2003 1279 1281 (Pubitemid 36773467)
176. M.T. Ziolo, and B.J. Biesiadecki Moving into a new neighborhood: NOS goes nuclear J Mol Cell Cardiol 62 2013 214 216
177. M.T. Ziolo, S.J. Dollinger, and G.M. Wahler Myocytes isolated from rejecting transplanted rat hearts exhibit reduced basal shortening which is reversible by aminoguanidine J Mol Cell Cardiol 30 1998 1009 1017 (Pubitemid 28279313)
178. M.T. Ziolo, C.H. Harshbarger, K.E. Roycroft, J.M. Smith, F.D. Romano, and K.L. Sondgeroth et al. Myocytes isolated from rejecting transplanted rat hearts exhibit a nitric oxide-mediated reduction in the calcium current J Mol Cell Cardiol 33 2001 1691 1699 (Pubitemid 32844226)
179. M.T. Ziolo, H. Katoh, and D.M. Bers Expression of inducible nitric oxide synthase depresses beta-adrenergic-stimulated calcium release from the sarcoplasmic reticulum in intact ventricular myocytes Circulation 104 2001 2961 2966 (Pubitemid 33139110)
180. M.T. Ziolo, M.J. Kohr, and H. Wang Nitric oxide signaling and the regulation of myocardial function J Mol Cell Cardiol 45 2008 625 632
181. M.T. Ziolo, S.J. Lewandowski, J.M. Smith, F.D. Romano, and G.M. Wahler Inhibition of cyclic GMP hydrolysis with zaprinast reduces basal and cyclic AMP-elevated l-type calcium current in guinea-pig ventricular myocytes Br J Pharmacol 138 2003 986 994 (Pubitemid 36390656)
182. M.T. Ziolo, L.S. Maier, V. Piacentino III, J. Bossuyt, S.R. Houser, and D.M. Bers Myocyte nitric oxide synthase 2 contributes to blunted beta-adrenergic response in failing human hearts by decreasing Ca2+ transients Circulation 109 2004 1886 1891 (Pubitemid 38509124)
183. M.H. Zou, C. Shi, and R.A. Cohen Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite J Clin Invest 109 2002 817 826 (Pubitemid 34263158)